AxoGen Management
Management criteria checks 1/4
AxoGen's CEO is Karen Zaderej, appointed in Sep 2011, has a tenure of 12.67 years. total yearly compensation is $5.53M, comprised of 12.6% salary and 87.4% bonuses, including company stock and options. directly owns 2.62% of the company’s shares, worth €6.87M. The average tenure of the management team and the board of directors is 0.8 years and 4.3 years respectively.
Key information
Karen Zaderej
Chief executive officer
US$5.5m
Total compensation
| CEO salary percentage | 12.6% |
| CEO tenure | 12.7yrs |
| CEO ownership | 2.6% |
| Management average tenure | less than a year |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$6m | US$700k | -US$22m |
| Sep 30 2023 | n/a | n/a | -US$23m |
| Jun 30 2023 | n/a | n/a | -US$23m |
| Mar 31 2023 | n/a | n/a | -US$25m |
| Dec 31 2022 | US$4m | US$674k | -US$29m |
| Sep 30 2022 | n/a | n/a | -US$29m |
| Jun 30 2022 | n/a | n/a | -US$32m |
| Mar 31 2022 | n/a | n/a | -US$32m |
| Dec 31 2021 | US$5m | US$651k | -US$27m |
| Sep 30 2021 | n/a | n/a | -US$28m |
| Jun 30 2021 | n/a | n/a | -US$22m |
| Mar 31 2021 | n/a | n/a | -US$22m |
| Dec 31 2020 | US$4m | US$561k | -US$24m |
| Sep 30 2020 | n/a | n/a | -US$25m |
| Jun 30 2020 | n/a | n/a | -US$29m |
| Mar 31 2020 | n/a | n/a | -US$28m |
| Dec 31 2019 | US$1m | US$605k | -US$29m |
| Sep 30 2019 | n/a | n/a | -US$27m |
| Jun 30 2019 | n/a | n/a | -US$26m |
| Mar 31 2019 | n/a | n/a | -US$26m |
| Dec 31 2018 | US$4m | US$575k | -US$22m |
| Sep 30 2018 | n/a | n/a | -US$20m |
| Jun 30 2018 | n/a | n/a | -US$18m |
| Mar 31 2018 | n/a | n/a | -US$12m |
| Dec 31 2017 | US$4m | US$463k | -US$10m |
Compensation vs Market: Karen's total compensation ($USD5.53M) is above average for companies of similar size in the German market ($USD689.54K).
Compensation vs Earnings: Karen's compensation has increased whilst the company is unprofitable.
CEO
Karen Zaderej (61 yo)
12.7yrs
Tenure
US$5,534,681
Compensation
Ms. Karen Zaderej has been President and Chief Executive Officer of AxoGen, Inc. since September 30, 2011. She is Independent Director of EyePoint Pharmaceuticals, Inc. from July 2022. She was the Director...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 12.7yrs | US$5.53m | 2.62% $ 6.9m | |
| Chief Financial Officer | less than a year | US$509.68k | no data | |
| Chief Innovation Officer | less than a year | US$1.51m | 0.29% $ 765.9k | |
| Vice President of Operations | less than a year | no data | no data | |
| Vice President of Finance & Investor Relations | no data | no data | no data | |
| Executive VP | 1.2yrs | no data | no data | |
| Vice President of Sales | 2.3yrs | no data | no data | |
| Chief Marketing Officer | 1.3yrs | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data |
0.8yrs
Average Tenure
51.5yo
Average Age
Experienced Management: LT3's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 12.7yrs | US$5.53m | 2.62% $ 6.9m | |
| Independent Director | 3.7yrs | US$220.00k | 0.022% $ 57.1k | |
| Independent Director | 8.8yrs | US$217.50k | 0.16% $ 410.1k | |
| Director | 12.7yrs | US$205.00k | 0.62% $ 1.6m | |
| Member of Board of Advisor | no data | no data | no data | |
| Member of Board of Advisor | no data | no data | no data | |
| Independent Director | 2.8yrs | US$215.00k | 0.015% $ 38.8k | |
| Independent Director | less than a year | US$293.37k | no data | |
| Independent Director | 5yrs | US$217.50k | 0.042% $ 109.7k | |
| Independent Lead Director | 7.7yrs | US$255.00k | 0.18% $ 482.7k | |
| Independent Director | 1.8yrs | US$220.00k | 0.037% $ 96.1k | |
| Independent Director | 1.4yrs | US$205.00k | 0% $ 0 |
4.3yrs
Average Tenure
61yo
Average Age
Experienced Board: LT3's board of directors are considered experienced (4.3 years average tenure).